The Importance of Appropriate Dosing of Nonvitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation. | TH Open;5(3): e353-e362, 2021 Jul. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

The Importance of Appropriate Dosing of Nonvitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation.

Beyer-Westendorf, Jan; Fay, Matthew; Amara, Walid.

Affiliation

Beyer-Westendorf J; Thrombosis Research Unit, Division Hematology, Department of Medicine I, University Hospital "Carl Gustav Carus" Dresden, Dresden, Germany.
Fay M; Department of Haematology, Kings Thrombosis Service, Kings College London, United Kingdom.
Amara W; Westcliffe Medical Practice, Westcliffe Road, Shipley, United Kingdom.

TH Open ; 5(3): e353-e362, 2021 Jul.

Article in En | MEDLINE | ID: mdl-34435170

Key words

anticoagulants; atrial fibrillation; stroke

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: TH Open Year: 2021 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: TH Open Year: 2021 Document type: Article Affiliation country: Country of publication: